Cardiology

Don't drink peroxide, even if alternative medicine promotes it.

Emergency departments' experience matters in treating atrial fibrillation.

Smartphone screening for atrial fibrillation goes big in Hong Kong.

The electrode-covered vest can map the heart after capturing a single heartbeat.

FDA approved the VBX Stent Graft to treat restenotic lesions in iliac arteries.

The MD Magazine editors rounded up the 10 best stories from January—did you read them all?

Patients with insulin resistance using Actos had reduced risk of CV death.

Endotracheal intubation may do more harm than good.

Are fixed-dose antihypertensives here to stay? How does the newest combination work? Try this spot-check quiz.

The Cardiovascular Health Study identifies patient factors that can be modified to stem risk for CEA.

Drugs won't work if patients don't take them.

Cognitive assessment is not improved by lifestyle interventions in diabetes. Health is.

The frequency of hypoglycemic episodes affects carotid atherosclerosis in patients with type 1 diabetes.

Break out the blue paint for women with higher preconception blood pressure.

Heart disease risk factors, not occupation, were linked to shoulder pain.

Could cyber-terorrists turn a cardiac pacemaker into a weapon? It sounded like fiction until the FDA and a device maker today announced that they had fixed a popular device precisely to prevent that from happening.

Heartburn drugs like Prilosec and Nexium might alleviate acid reflux, but could raise the risk of severe stomach infections.

In a dramatic decision on a long-running patent dispute over alirocumab vs. evolocumab, a federal court judge ruled that Amgen's patents were violated and that rivals Sanofi/Regeneron can no longer distribute their product.

The lifesaving potential in a statin Rx should motivate us to try, try again if side effects lead to discontinuation.

Should physicians critically reconsider their management strategy for ACS in a broad spectrum of patients with ACS

The MD Magazine editors rounded up the 10 best stories from December—did you read them all?

In a new study, stroke occurred in 6.6% of the ranibizumab-treated group, compared with 7.0% of the controls matched by sociodemographic factors and comorbidities and 6.7% of the controls matched by sociodemographic factors only. These differences were not statistically significant.

The US Food and Drug Administration approved dropping black box warning on two smoking cessation aids.

Maryland researchers found that even mild hypoglycemia can pose a cardiovascular risk in obese people with diabetes.

A retrospective analysis of nutrition studies showed magnesium can reduce heart failure and diabetes risk. The key is dosage, a team found.

Despite the fact that two thirds of stroke survivors could suffer from a visual impairment, nearly half of stroke units do not even assess vision. A recent report suggests that more must be done to assess the outlook for vision in stroke survivors.

The latest tallies on US life expectancy show its down a bit.

Empagliflozin was approved to reduce heart and stroke risk in patients with diabetes.

Several studies have shown that patients with sleep apnea are more likely than others to develop atrial fibrillation, but recent information indicates that any type of disrupted sleep may indicate an elevated risk.